http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2893469-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b86e50a7529f6158517db14a0b81df |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a42b7947c5a88824c7bfa030827a17f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95036778b78ace3a497c4f4a0bffb60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c0b7e186455ac0e06e03fe3e9fb9e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab73b2eda88854c289554a667826879 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3f42921ec6913a601f7278ed771eed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e687e80e16df4cc4a0f45452c0ef208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb6c56743be3a411a2b20bd6c1a21ad7 |
| publicationDate | 2022-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2893469-T3 |
| titleOfInvention | Risk Scores Based on Human Phosphodiesterase 4D Variant 7 Expression |
| abstract | Risk stratification method, comprising: determining a normalized gene expression profile for a single marker gene consisting of phosphodiesterase 4D variant 7 (PDE4D7) relative to a set of one or more reference genes selected from the group consisting of: hypoxanthine Homo sapiens phosphoribosyltransferase 1 (HPRT1), Homo sapiens tubulin-alpha-Ib (TUBA1B), Homo sapiens Pumilio RNA-binding protein family member (PUM1), and Homo sapiens TATA box-binding protein (TBP), and combinations thereof, determine a prognostic risk score with a scoring function, based on the normalized gene expression profile, where the scoring function has been derived from gene expression genes for biological samples obtained from subjects who have been monitored for prostate cancer, and determine a combined prognostic risk score based on the prognostic risk score and a second determination of r risk that is the classification of the National Comprehensive Cancer Network (NCCN). |
| priorityDate | 2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.